PL352387A1 - Pharmaceutical composition containing sibutramine and a lipase inhibitor - Google Patents

Pharmaceutical composition containing sibutramine and a lipase inhibitor

Info

Publication number
PL352387A1
PL352387A1 PL00352387A PL35238700A PL352387A1 PL 352387 A1 PL352387 A1 PL 352387A1 PL 00352387 A PL00352387 A PL 00352387A PL 35238700 A PL35238700 A PL 35238700A PL 352387 A1 PL352387 A1 PL 352387A1
Authority
PL
Poland
Prior art keywords
pharmaceutical composition
composition containing
lipase inhibitor
containing sibutramine
sibutramine
Prior art date
Application number
PL00352387A
Other languages
English (en)
Inventor
Alan Martin Birch
David John Heal
Original Assignee
Knoll Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Gmbh filed Critical Knoll Gmbh
Publication of PL352387A1 publication Critical patent/PL352387A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL00352387A 1999-06-24 2000-06-16 Pharmaceutical composition containing sibutramine and a lipase inhibitor PL352387A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9914742.3A GB9914742D0 (en) 1999-06-24 1999-06-24 Therapeutic agents

Publications (1)

Publication Number Publication Date
PL352387A1 true PL352387A1 (en) 2003-08-25

Family

ID=10855953

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00352387A PL352387A1 (en) 1999-06-24 2000-06-16 Pharmaceutical composition containing sibutramine and a lipase inhibitor

Country Status (20)

Country Link
EP (1) EP1189638A2 (hu)
JP (1) JP2003503344A (hu)
KR (1) KR20020012293A (hu)
CN (1) CN1365287A (hu)
AU (1) AU5815100A (hu)
BG (1) BG106209A (hu)
BR (1) BR0011884A (hu)
CA (1) CA2376213A1 (hu)
CZ (1) CZ20014614A3 (hu)
GB (1) GB9914742D0 (hu)
HK (1) HK1050476A1 (hu)
HU (1) HUP0201880A3 (hu)
IL (1) IL147078A0 (hu)
MX (1) MXPA01013023A (hu)
NO (1) NO20016301L (hu)
PL (1) PL352387A1 (hu)
SK (1) SK18822001A3 (hu)
TR (1) TR200103704T2 (hu)
WO (1) WO2001000187A2 (hu)
ZA (1) ZA200110046B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399826B1 (en) * 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
US7089666B2 (en) * 2003-06-06 2006-08-15 The Regents Of The University Of California Microfabricated vertical comb actuator using plastic deformation
JP2010503709A (ja) 2006-09-15 2010-02-04 レビバ ファーマシューティカルズ,インコーポレーテッド シクロアルキルメチルアミンの合成、使用方法および組成物
CN101890017A (zh) * 2009-05-22 2010-11-24 北京奥萨医药研究中心有限公司 含有西布曲明和他汀类降脂药物的药物组合物及其用途
WO2012003501A2 (en) 2010-07-02 2012-01-05 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
US9238625B2 (en) 2011-12-30 2016-01-19 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives

Also Published As

Publication number Publication date
NO20016301D0 (no) 2001-12-21
ZA200110046B (en) 2003-03-06
KR20020012293A (ko) 2002-02-15
TR200103704T2 (tr) 2002-05-21
CA2376213A1 (en) 2001-01-04
HUP0201880A3 (en) 2003-03-28
HUP0201880A2 (hu) 2002-12-28
GB9914742D0 (en) 1999-08-25
BR0011884A (pt) 2003-08-12
AU5815100A (en) 2001-01-31
MXPA01013023A (es) 2003-08-01
CZ20014614A3 (cs) 2004-02-18
IL147078A0 (en) 2002-08-14
NO20016301L (no) 2001-12-21
CN1365287A (zh) 2002-08-21
EP1189638A2 (en) 2002-03-27
HK1050476A1 (zh) 2003-06-27
WO2001000187A2 (en) 2001-01-04
SK18822001A3 (sk) 2003-04-01
WO2001000187A3 (en) 2001-11-15
JP2003503344A (ja) 2003-01-28
BG106209A (en) 2002-09-30

Similar Documents

Publication Publication Date Title
EP1071403A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING STATIN AND ASPIRIN
ZA98376B (en) Sulfamide-metalloprotease inhibitors
PL336625A1 (en) Protease inhibitors
GB2321641B (en) Sulfamide-metalloprotease inhibitors
PL336589A1 (en) Serinic protease inhibitors
PL339429A1 (en) Urokinase inhibitors
ZA988469B (en) Pyrrolidin-2-one compounds and their use as neuraminidase inhibitors
IL135428A0 (en) Ace inhibitor-mmp inhibitor combinations
PL336856A1 (en) Protease inhibitors
PL337755A1 (en) Protease inhibitors
IL132629A0 (en) Protease inhibitors
AU9640698A (en) Pharmaceutical combination of a cyclooxigenase-2 inhibitor and acetaminophen or an opiate
AU6422298A (en) Pharmaceutical composition containing a phosphorylamide and an ayntibiotic
AU9061798A (en) Protease variants and compositions
PL352387A1 (en) Pharmaceutical composition containing sibutramine and a lipase inhibitor
EP1015438A4 (en) PROTEASE INHIBITORS
HUP0001976A3 (en) Antiviral protease inhibitors and pharmaceutical compositions
GB9815925D0 (en) HIV Intergrase inhibitors
EP0975612A4 (en) PROTEASE INHIBITORS
AU9061898A (en) Protease variants and compositions
GB9907469D0 (en) Labels and manufacture thereof
ZA200100696B (en) Pharmaceutical compositions containing lipase inhibitors
GB9713709D0 (en) Inhibitors
GB9703335D0 (en) Inhibitors
GB9709064D0 (en) Inhibitors